SEC Form 4 · accession 0000899243-17-028955
PROVECTUS BIOPHARMACEUTICALS, INC. · PVCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John R Glass
Officer — See Remarks
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 12:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000315545
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2017 | P | 84,100 | $0.0539 | A | 84,100 | D | |
| Common Stock | Dec 14, 2017 | P | 115,900 | $0.054 | A | 200,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Interim Chief Financial Officer